Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Cancer Care industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novartis AG
Celgene Corporation
Bayer AG
GlaxoSmithKline PLC
Bristol Myers Squibb Company
Astellas Pharma Inc
Celldex Therapeutics Inc
Merck & Co Inc
Pfizer Inc
Ziopharm Oncology Inc
FHoffmann-La Roche AG
Amgen Inc
Astrazeneca PLC
Abbvie Inc
Takeda Pharmaceutical Company Ltd
By Type:
Hormonal Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Other Treatment Types
By Application:
Hospitals
Cancer and Radiation Therapy Centers
Specialty Clinics
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Cancer Care Market Overview 2018-2029
-
1.1 China Cancer Care Industry Development Overview
-
1.2 China Cancer Care Industry Development History
-
1.3 China Cancer Care Industry Market Size (2018-2029)
-
1.4 China Cancer Care Market Analysis by Type from Production Side
-
1.4.1 China Cancer Care Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)
-
1.4.2 China Cancer Care Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)
-
1.4.3 China Cancer Care Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)
-
1.4.4 China Cancer Care Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)
-
1.4.5 China Cancer Care Production Volume, Production Value and Growth Rate of Other Treatment Types (2018-2029)
-
1.5 China Cancer Care Market Analysis by Application from Consumption End
-
1.5.1 China Cancer Care Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.2 China Cancer Care Sales Volume, Sales Value and Growth Rate of Cancer and Radiation Therapy Centers (2018-2029)
-
1.5.3 China Cancer Care Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)
-
1.6 China Cancer Care Market Analysis by Region
-
1.6.1 North China Cancer Care Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Cancer Care Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Cancer Care Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Cancer Care Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Cancer Care Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Cancer Care Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Cancer Care Market Size and Growth Rate from 2018-2029
Chapter 2 China Cancer Care Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Cancer Care Market Status and Competition at home and abroad in 2023
-
2.2.2 China Cancer Care Market Status and Competition Analysis in 2023
-
2.2.3 China Cancer Care Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Cancer Care Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Cancer Care Industry Development
Chapter 3 Cancer CareIndustry Chain Analysis
-
3.1 Cancer Care Industry Chain
-
3.2 Cancer Care Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Cancer Care Market
-
3.3 Cancer Care Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Cancer Care Market
Chapter 4 China Cancer Care Market, by Type
-
4.1 China Cancer Care Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Cancer Care Total Production Volume and Growth Rate from Production Side
-
4.5 China Cancer Care Production Volume and Growth Rate, by Type
-
4.5.1 China Cancer Care Production Volume and Growth Rate of Hormonal Therapy
-
4.5.2 China Cancer Care Production Volume and Growth Rate of Chemotherapy
-
4.5.3 China Cancer Care Production Volume and Growth Rate of Immunotherapy
-
4.5.4 China Cancer Care Production Volume and Growth Rate of Targeted Therapy
-
4.5.5 China Cancer Care Production Volume and Growth Rate of Other Treatment Types
Chapter 5 China Cancer Care Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Cancer Care Total Market Size and Growth Rate from Consumption End
-
5.5 China Cancer Care Market Size and Growth Rate, by Application
-
5.5.1 China Cancer Care Market Size and Growth Rate of Hospitals
-
5.5.2 China Cancer Care Market Size and Growth Rate of Cancer and Radiation Therapy Centers
-
5.5.3 China Cancer Care Market Size and Growth Rate of Specialty Clinics
Chapter 6 China Cancer Care Market, by Region
-
6.1 China Cancer Care Production Volume and Production Value, by Region
-
6.2 China Cancer Care Sales Volume and Sales Value, by Region
Chapter 7 North China Cancer Care Market Analysis
-
7.1 North China Cancer Care Market, by Type
-
7.2 North China Cancer Care Market, by Application
Chapter 8 Central China Cancer Care Market Analysis
-
8.1 Central China Cancer Care Market, by Type
-
8.2 Central China Cancer Care Market, by Application
Chapter 9 South China Cancer Care Market Analysis
-
9.1 South China Cancer Care Market, by Type
-
9.2 South China Cancer Care Market, by Application
Chapter 10 East China Cancer Care Market Analysis
-
10.1 East China Cancer Care Market, by Type
-
10.2 East China Cancer Care Market, by Application
Chapter 11 Northeast China Cancer Care Market Analysis
-
11.1 Northeast China Cancer Care Market, by Type
-
11.2 Northeast China Cancer Care Market, by Application
Chapter 12 Southwest China Cancer Care Market Analysis
-
12.1 Southwest China Cancer Care Market, by Type
-
12.2 Southwest China Cancer Care Market, by Application
Chapter 13 Northwest China Cancer Care Market Analysis
-
13.1 Northwest China Cancer Care Market, by Type
-
13.2 Northwest China Cancer Care Market, by Application
Chapter 14 Company Profiles
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Profile
-
14.1.2 Novartis AG Cancer Care Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Celgene Corporation
-
14.2.1 Celgene Corporation Company Profile
-
14.2.2 Celgene Corporation Cancer Care Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Bayer AG
-
14.3.1 Bayer AG Company Profile
-
14.3.2 Bayer AG Cancer Care Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GlaxoSmithKline PLC
-
14.4.1 GlaxoSmithKline PLC Company Profile
-
14.4.2 GlaxoSmithKline PLC Cancer Care Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Bristol Myers Squibb Company
-
14.5.1 Bristol Myers Squibb Company Company Profile
-
14.5.2 Bristol Myers Squibb Company Cancer Care Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Astellas Pharma Inc
-
14.6.1 Astellas Pharma Inc Company Profile
-
14.6.2 Astellas Pharma Inc Cancer Care Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Celldex Therapeutics Inc
-
14.7.1 Celldex Therapeutics Inc Company Profile
-
14.7.2 Celldex Therapeutics Inc Cancer Care Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Merck & Co Inc
-
14.8.1 Merck & Co Inc Company Profile
-
14.8.2 Merck & Co Inc Cancer Care Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Pfizer Inc
-
14.9.1 Pfizer Inc Company Profile
-
14.9.2 Pfizer Inc Cancer Care Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Ziopharm Oncology Inc
-
14.10.1 Ziopharm Oncology Inc Company Profile
-
14.10.2 Ziopharm Oncology Inc Cancer Care Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 FHoffmann-La Roche AG
-
14.11.1 FHoffmann-La Roche AG Company Profile
-
14.11.2 FHoffmann-La Roche AG Cancer Care Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Amgen Inc
-
14.12.1 Amgen Inc Company Profile
-
14.12.2 Amgen Inc Cancer Care Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Astrazeneca PLC
-
14.13.1 Astrazeneca PLC Company Profile
-
14.13.2 Astrazeneca PLC Cancer Care Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Abbvie Inc
-
14.14.1 Abbvie Inc Company Profile
-
14.14.2 Abbvie Inc Cancer Care Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Takeda Pharmaceutical Company Ltd
-
14.15.1 Takeda Pharmaceutical Company Ltd Company Profile
-
14.15.2 Takeda Pharmaceutical Company Ltd Cancer Care Market Performance
-
14.15.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Cancer Care Industry Research Conclusions
-
15.2 Cancer Care Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Cancer Care Industry Market Size (2018-2029)
-
Figure China Cancer Care Production Volume, Production Value and Growth Rate of Hormonal Therapy (2018-2029)
-
Figure China Cancer Care Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)
-
Figure China Cancer Care Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)
-
Figure China Cancer Care Production Volume, Production Value and Growth Rate of Targeted Therapy (2018-2029)
-
Figure China Cancer Care Production Volume, Production Value and Growth Rate of Other Treatment Types (2018-2029)
-
Figure China Cancer Care Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China Cancer Care Sales Volume, Sales Value and Growth Rate of Cancer and Radiation Therapy Centers (2018-2029)
-
Figure China Cancer Care Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)
-
Figure North China Cancer Care Market Size and Growth Rate from 2018-2029
-
Figure Central China Cancer Care Market Size and Growth Rate from 2018-2029
-
Figure South China Cancer Care Market Size and Growth Rate from 2018-2029
-
Figure East China Cancer Care Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Cancer Care Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Cancer Care Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Cancer Care Market Size and Growth Rate from 2018-2029
-
Figure Cancer Care Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Cancer Care Market Share by Type in 2018
-
Figure China Cancer Care Market Share by Type in 2023
-
Figure China Cancer Care Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Cancer Care Production Volume and Growth Rate of Hormonal Therapy (2018-2023)
-
Figure China Cancer Care Production Volume and Growth Rate of Chemotherapy (2018-2023)
-
Figure China Cancer Care Production Volume and Growth Rate of Immunotherapy (2018-2023)
-
Figure China Cancer Care Production Volume and Growth Rate of Targeted Therapy (2018-2023)
-
Figure China Cancer Care Production Volume and Growth Rate of Other Treatment Types (2018-2023)
-
Figure China Cancer Care Market Share by Application in 2018
-
Figure China Cancer Care Market Share by Application in 2023
-
Figure China Cancer Care Total Market Size and Growth Rate from Consumption End
-
Figure China Cancer Care Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China Cancer Care Market Size and Growth Rate of Cancer and Radiation Therapy Centers (2018-2023)
-
Figure China Cancer Care Market Size and Growth Rate of Specialty Clinics (2018-2023)
-
Table China Cancer Care Production Volume by Region (2018-2023)
-
Table China Cancer Care Production Volume Share by Region (2018-2023)
-
Figure China Cancer Care Production Volume Share by Region (2018-2023)
-
Table China Cancer Care Production Value by Region (2018-2023)
-
Table China Cancer Care Production Value Share by Region (2018-2023)
-
Figure China Cancer Care Production Value Share by Region (2018-2023)
-
Table China Cancer Care Sales Volume by Region (2018-2023)
-
Table China Cancer Care Sales Volume Share by Region (2018-2023)
-
Figure China Cancer Care Sales Volume Share by Region (2018-2023)
-
Table China Cancer Care Sales Value by Region (2018-2023)
-
Table China Cancer Care Sales Value Share by Region (2018-2023)
-
Figure China Cancer Care Sales Value Share by Region (2018-2023)
-
Table North China Cancer Care Production Volume by Type (2018-2023)
-
Table North China Cancer Care Production Volume Share by Type (2018-2023)
-
Figure North China Cancer Care Production Volume Share by Type (2018-2023)
-
Table North China Cancer Care Sales Volume by Application (2018-2023)
-
Table North China Cancer Care Sales Volume Share by Application (2018-2023)
-
Figure North China Cancer Care Sales Volume Share by Application (2018-2023)
-
Table Central China Cancer Care Production Volume by Type (2018-2023)
-
Table Central China Cancer Care Production Volume Share by Type (2018-2023)
-
Figure Central China Cancer Care Production Volume Share by Type (2018-2023)
-
Table Central China Cancer Care Sales Volume by Application (2018-2023)
-
Table Central China Cancer Care Sales Volume Share by Application (2018-2023)
-
Figure Central China Cancer Care Sales Volume Share by Application (2018-2023)
-
Table South China Cancer Care Production Volume by Type (2018-2023)
-
Table South China Cancer Care Production Volume Share by Type (2018-2023)
-
Figure South China Cancer Care Production Volume Share by Type (2018-2023)
-
Table South China Cancer Care Sales Volume by Application (2018-2023)
-
Table South China Cancer Care Sales Volume Share by Application (2018-2023)
-
Figure South China Cancer Care Sales Volume Share by Application (2018-2023)
-
Table East China Cancer Care Production Volume by Type (2018-2023)
-
Table East China Cancer Care Production Volume Share by Type (2018-2023)
-
Figure East China Cancer Care Production Volume Share by Type (2018-2023)
-
Table East China Cancer Care Sales Volume by Application (2018-2023)
-
Table East China Cancer Care Sales Volume Share by Application (2018-2023)
-
Figure East China Cancer Care Sales Volume Share by Application (2018-2023)
-
Table Northeast China Cancer Care Production Volume by Type (2018-2023)
-
Table Northeast China Cancer Care Production Volume Share by Type (2018-2023)
-
Figure Northeast China Cancer Care Production Volume Share by Type (2018-2023)
-
Table Northeast China Cancer Care Sales Volume by Application (2018-2023)
-
Table Northeast China Cancer Care Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Cancer Care Sales Volume Share by Application (2018-2023)
-
Table Southwest China Cancer Care Production Volume by Type (2018-2023)
-
Table Southwest China Cancer Care Production Volume Share by Type (2018-2023)
-
Figure Southwest China Cancer Care Production Volume Share by Type (2018-2023)
-
Table Southwest China Cancer Care Sales Volume by Application (2018-2023)
-
Table Southwest China Cancer Care Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Cancer Care Sales Volume Share by Application (2018-2023)
-
Table Northwest China Cancer Care Production Volume by Type (2018-2023)
-
Table Northwest China Cancer Care Production Volume Share by Type (2018-2023)
-
Figure Northwest China Cancer Care Production Volume Share by Type (2018-2023)
-
Table Northwest China Cancer Care Sales Volume by Application (2018-2023)
-
Table Northwest China Cancer Care Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Cancer Care Sales Volume Share by Application (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Celgene Corporation Company Profile
-
Table Celgene Corporation Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Bayer AG Company Profile
-
Table Bayer AG Cancer Care Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline PLC Company Profile
-
Table GlaxoSmithKline PLC Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Bristol Myers Squibb Company Company Profile
-
Table Bristol Myers Squibb Company Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Astellas Pharma Inc Company Profile
-
Table Astellas Pharma Inc Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Celldex Therapeutics Inc Company Profile
-
Table Celldex Therapeutics Inc Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Merck & Co Inc Company Profile
-
Table Merck & Co Inc Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Pfizer Inc Company Profile
-
Table Pfizer Inc Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Ziopharm Oncology Inc Company Profile
-
Table Ziopharm Oncology Inc Cancer Care Revenue, Price and Gross (2018-2023)
-
Table FHoffmann-La Roche AG Company Profile
-
Table FHoffmann-La Roche AG Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Amgen Inc Company Profile
-
Table Amgen Inc Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Astrazeneca PLC Company Profile
-
Table Astrazeneca PLC Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Abbvie Inc Company Profile
-
Table Abbvie Inc Cancer Care Revenue, Price and Gross (2018-2023)
-
Table Takeda Pharmaceutical Company Ltd Company Profile
-
Table Takeda Pharmaceutical Company Ltd Cancer Care Revenue, Price and Gross (2018-2023)
-
